Navigation Links
Significant Advances in VCJD Prion Detection

Scientists have made significant advances towards the development of a technique that could be used to confirm whether someone is infected with variant CJD .

The technique, which has so far been used mainly in animal models, works by mimicking and accelerating the replication of prions - abnormal proteins that progressively kill off brain tissue and are thought to cause the disease.

The method, known as known as Protein Misfolding Cyclic Amplification (PMCA), enables the level of prions to be increased so that they can be recognised by existing detection methods.

Researchers have shown for the first time that the number of vCJD prions can be amplified from infected human brain tissue extracts prepared from normal human platelets - a type of blood cell essential for clotting.

The sample is incubated and exposed to repeated rounds of ultrasound, which break the prions up into more numerous smaller particles.

The research was carried out by the University of Edinburgh National CJD Surveillance Unit working with the Scottish National Blood Transfusion Service, the Neuropathogenis Unit at the Roslin Institute and CSL Behring, However, more research is urgently needed to ensure that the technique, which has been applied to brain tissue, can be applied to other tissues, such as blood, that might be used in tests for vCJD.

Professor James Ironside, of the National CJD Surveillance Unit at the University of Edinburgh, said: While this method, due to the length of time it takes to carry out, is unlikely to produce a rapid screening test that could be implemented in blood donation centres it may well be suitable as a confirmatory test that could be conducted at a national centre.

Work is currently ongoing to develop a screening test for vCJD but one of the issues common to various screening tests is that of false positive results.

By developing a reliable confirmatory t
'"/>




Page: 1 2

Related medicine news :

1. Inhaled Corticosteroids Found To Have No Significant Effect On COPD
2. A Little Weight Loss Found To Make A Significant Difference In Men
3. New Drug Shows Significant Improvement In HIV-related Heart Condition
4. Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer
5. Kidney Disease, More Significant Risk Factor For Heart Disease Than Obesity
6. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
7. Biomarkers Could Prove Significant In Understanding Aging Process
8. Smoke From Cooking Fuels Cause A Significant Number Of Death Worldwide
9. Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure
10. Significant Advance in Treatment of Breast Cancer Reported
11. Significant role of genetics in drug abuse, Norwegian study
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...moking is associated with an increased risk of dis... A new study has highlighted that smoker’s childre... a bacteria that can cause pneumonia, sinusitis an...e in the cigarette price, ban on smoking seems to ...
...dental health a common concern is fluoride which i... teeth.// This is a revelation of several studies ...ntal Research's annual meeting from March 8, 2006,...da. Some important findings and studies are as men...
... prescribed by the physicians to those in the cate...normal heart rhythm. They are less commonly given ...m are the highest. In case of elders also those wh...llation, are not prescribed warfarin when they are...
Health Industry On An Upward Swing In Germany
Other Medicine News:Health News:Warfarin the Not So Popular Drug for Stroke 2
(Date:9/4/2008)...potent antiviral activity and favorable safety ...Mass., Sept. 4 /- Idenix,Ph...eutical company engaged,in the discovery and devel...nd other infectious diseases, today announced that...ating IDX899, a non-nucleoside reverse,transcripta...
(Date:9/3/2008)...- Simcere,Pharmaceutical Gr...lier of,branded generic pharmaceuticals and manufa... Endu (also known as Endostar) in China,announced...dy., At the request of the SFDA, Simcere initiate...e safety and therapeutic efficacy of Endu, a modif...
(Date:9/3/2008)...3 /- Panacea Pharmaceuticals,Inc. to...,413,737 covering,antibodies against human asparty...tary human cancer biomarker and therapeutic target... with the Massachusetts Institute of,Technology (M... this patent,for development of human cancer diagn...
(Date:9/3/2008)...n Repeat-Dosing Study in Subjects with ALS, RICHM...gamo,BioSciences, Inc. (Nasdaq: SGMO ) announced ...(SB-509-801) to evaluate its drug, SB-509, in subj...euron disease for which there,are limited treatmen...s an injectable formulation of a plasmid,encoding ...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5MedQuest Standardizes on AMICAS Vision Series PACS 7008 1MedQuest Standardizes on AMICAS Vision Series PACS 7008 2MedQuest Standardizes on AMICAS Vision Series PACS 7008 3Drug Safety Experts Call for Increased Patient Involvement 7006 1Drug Safety Experts Call for Increased Patient Involvement 7006 2Drug Safety Experts Call for Increased Patient Involvement 7006 3Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 7004 1Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 7004 2Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 7004 3Phoenix Fire Chief Bob Khan Encourages Arizonans to Get Vaccinated Against Influenza 7004 4January 1 Looms Large for Lymphoma Patients 7002 1January 1 Looms Large for Lymphoma Patients 7002 2
...-(BUSINESS WIRE)--May 23, 2007 - CytoGenix, Inc. (...Scientific Officer will,present an update on precl... Company,s proprietary synDNA(TM) technology at th...a, Spain between May 23,and May 25., Dr. Chen comm...DNA(TM) based vaccines in mice, rabbits and non-hu...
...N, N.J.--(BUSINESS WIRE)--May 23, 2007 - Cytogen,C...cation of a,review validating the utility of its P...f the WW domain-containing oxidoreductase,(WWOX), ...lvement,in breast, prostate, lung, pancreatic, eso...ticle was published in the online,edition (25 Apri...
Other Medicine Technology:CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 2Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 3Cytogen Reports Publication Validating the Utility of its,Proprietary ProChart Database 4
SmartOffice Plus is a CO2 laser system with continuous intensities up to 25 W. Its functions in continuous and super-pulsed mode are ideal for surgery requiring extreme laser intervention delicacy. E
Auto Refkeratomoeter
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions.
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology.
Medicine Products: